The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Chair: Prof. Refiloe Masekela (South Africa)
Speakers: Prof. Simon Schaff (South Africa), Dr. Clementien Vermont (Netherlands) and Dr. Moherndran Archary (South Africa)
Tuberculosis (TB) and Multidrug resistant tuberculosis (MDR) are important diseases that affect children globally. TB is still a cause of morbidity and mortality in many low to middle income country settings but is also increasingly seen in Europe, more so in Eastern European countries. Challenges with diagnosis of TB and duration of treatment and registration of new drugs are new opportunities for combating TB in 2022.
2 lectures, each 20 minutes long, followed by a 20-minute Q&A session.
An understanding of the various treatment options available to treat both TB and MDR TB as well as the new drugs that are currently in trial phase for TB/MDR TB.
